Literature DB >> 27882224

Correlation between serum parathyroid hormone levels and coronary artery calcification in patients without renal failure.

Gang-Yong Wu1, Bai-Da Xu1, Ting Wu1, Xiao-Ying Wang1, Tian-Xiao Wang1, Xiao Zhang1, Xiao Wang1, Yang Xia1, Gang-Jun Zong1.   

Abstract

The aim of the present study was to investigate the correlation between serum parathyroid hormone (PTH) levels and coronary artery calcification (CAC) in patients without renal failure, as well as to determine independent risk factors of CAC score (CACS). A total of 157 patients who underwent coronary computed tomography angiographic examination at the 101th Hospital of the People's Liberation Army between December 2013 and February 2015 were retrospectively evaluated. The correlation between PTH levels and CACS was determined using a Pearson correlation analysis. A receiver operating characteristic (ROC) curve was drawn to determine the best cutoff PTH level for prediction of CAC. The independent association between serum PTH levels and CAC was analyzed by using a logistic regression analysis model with the response variable Be binary class. The results revealed that PTH levels in patients in the CAC group were significantly higher than those of patients in the non-calcification group. PTH levels were positively correlated with CACS (r=0.288, P<0.001). The ROC curve suggested that a PTH level of ≥31.05 pg/ml was the best cut-off point for the prediction of CAC, with a sensitivity of 80.88%, specificity of 60.67% and an area under the curve of 0.761. After including predictive factors for CAC (gender, age, smoking status, diabetes, hypertension, hyperlipidemia, body mass index, glomerular filtration rate and calcium, phosphorus, calcium-phosphorus product, magnesium, PTH, total cholesterol, low-density lipoprotein cholesterol, triglyceride, high-density lipoprotein cholesterol and C-reactive protein levels), the odds ratio of the serum PTH levels regarding the prediction of CAC was 1.050 (95% confidence interval, 1.027-1.074; P<0.001). In conclusion, the present study suggested that serum PTH levels are correlated with CAC in patients without renal failure and may thus be used as a reliable predictor of CAC.

Entities:  

Keywords:  calcinosis; computed tomography angiography; coronary artery disease; parathyroid hormone

Year:  2016        PMID: 27882224      PMCID: PMC5103683          DOI: 10.3892/br.2016.761

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  31 in total

1.  Relationship between vitamin D deficiency and nondipper hypertension.

Authors:  Mehmet Demir; Tufan Günay; Gökhan Özmen; Mehmet Melek
Journal:  Clin Exp Hypertens       Date:  2012-05-17       Impact factor: 1.749

2.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

3.  [Chinese guidelines for the diagnosis and treatment of heart failure 2014].

Authors: 
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2014-02

4.  Prospective analysis of coronary calcium in patients on dialysis undergoing a near-total parathyroidectomy.

Authors:  William T Daniel; Collin Weber; James A Bailey; Paolo Raggi; Jyotirmay Sharma
Journal:  Surgery       Date:  2013-12       Impact factor: 3.982

5.  Association of mild to moderate kidney dysfunction and coronary calcification.

Authors:  Joachim H Ix; Ronit Katz; Bryan Kestenbaum; Linda F Fried; Holly Kramer; Catherine Stehman-Breen; Michael G Shlipak
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

6.  [Cardiac valves calcifications in dialysis patients].

Authors:  Dragan Klarić; Vera Klarić; Ivica Kristić
Journal:  Acta Med Croatica       Date:  2011-10

7.  Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study).

Authors:  Udo Hoffmann; Joseph M Massaro; Caroline S Fox; Emily Manders; Christopher J O'Donnell
Journal:  Am J Cardiol       Date:  2008-08-20       Impact factor: 2.778

8.  Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study.

Authors:  Catherine M Loria; Kiang Liu; Cora E Lewis; Stephen B Hulley; Stephen Sidney; Pamela J Schreiner; O Dale Williams; Diane E Bild; Robert Detrano
Journal:  J Am Coll Cardiol       Date:  2007-05-04       Impact factor: 24.094

9.  Interrelationship between haemodynamic state and serum intact parathyroid hormone levels in patients with chronic heart failure.

Authors:  Tadafumi Sugimoto; Kaoru Dohi; Katsuya Onishi; Kiyotaka Watanabe; Yuichi Sato; Emiyo Sugiura; Shiro Nakamori; Hiroshi Nakajima; Mashio Nakamura; Masaaki Ito
Journal:  Heart       Date:  2012-11-26       Impact factor: 5.994

10.  Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study.

Authors:  Elena Kamycheva; Johan Sundsfjord; Rolf Jorde
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2004-02
View more
  4 in total

Review 1.  Serum biomarkers for arterial calcification in humans: A systematic review.

Authors:  Nienke M S Golüke; Marit A Schoffelmeer; Annemarieke De Jonghe; Mariëlle H Emmelot-Vonk; Pim A De Jong; Huiberdina L Koek
Journal:  Bone Rep       Date:  2022-06-18

2.  Early Effects of Atorvastatin on Vitamin D and Parathyroid Hormone Serum Levels Following Acute Myocardial Infarction.

Authors:  Batool Zarei; Maryam Mousavi; Saeideh Mehdizadeh; Hassan Mehrad-Majd; Maryam Zarif; Zahra Erfanian; Ali Moradi
Journal:  J Res Pharm Pract       Date:  2019 Jan-Mar

3.  Increased Serum Parathyroid Hormone, Osteocalcin and Alkaline Phosphatase Are Associated with a Long-Term Adverse Cardiovascular Outcome after Coronary Artery Bypass Graft Surgery.

Authors:  Olga Barbarash; Mikhail Zykov; Vasiliy Kashtalap; Oksana Hryachkova; Alexandr Kokov; Olga Gruzdeva; Irina Shibanova; Anton Kutikhin
Journal:  Diagnostics (Basel)       Date:  2019-10-08

4.  A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism.

Authors:  Helen Eddington; Rajkumar Chinnadurai; Helen Alderson; Sara T Ibrahim; Constantina Chrysochou; Darren Green; Ibi Erekosima; Alastair Hutchison; Abdalla Bubtana; Janet Hegarty; Philip A Kalra
Journal:  BMC Nephrol       Date:  2021-03-23       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.